Table 1 Credible ranges and fitted distributions for cost of goods upstream
From: Stem cells and beta cell replacement therapy: a prospective health technology assessment study
Production setting | Range | Gamma distribution | |||||
|---|---|---|---|---|---|---|---|
Cell culture | Supply | Lower bound | Upper bound | Mean | RSD | Shape | Rate |
Adherent | 50 | $21,300 | $83,900 | $47,443 | 34.00% | 8.6505 | 0.0001823 |
Adherent | 500 | $14,700 | $73,800 | $38,585 | 39.60% | 6.3769 | 0.0001653 |
Suspension | 50 | $16,900 | $54,900 | $33,193 | 29.42% | 11.5535 | 0.0003481 |
Suspension | 500 | $10,300 | $53,100 | $27,535 | 40.20% | 6.1880 | 0.0002247 |